title: High serum galectin-3 in advanced melanoma: preliminary results.
abstract: BACKGROUND
  Galectin-3 (Gal-3) is a member of the family of beta-galactoside-binding mammalian lectins, and has been implicated in tumour invasion and metastatic process in vitro and in vivo.
  
  
  OBJECTIVE
  To determine whether an increase in serum Gal-3 production could be found in patients with advanced metastatic melanoma.
  
  
  METHODS
  We collected 18 sera from patients with AJCC stage IV metastatic melanomas and 20 sera from healthy volunteers. Determination of Gal-3 was performed by ELISA, and in the group of patients with melanoma, these results were compared with the serum lactate dehydrogenase (LDH) and the C-reactive protein (CRP) concentrations.
  
  
  RESULTS
  Gal-3 concentration was shown to be significantly higher in the group of patients with melanoma compared with healthy volunteers, and Gal-3 concentration was significantly correlated with both LDH and CRP in the melanoma group. We also selected four patients in the melanoma group for Gal-3 retrospective immunostaining analysis on cutaneous metastases. Two of these patients, who had a higher Gal-3 serum level, showed more intense staining and the other two patients, with a lower serum level of Gal-3, had moderate immunostaining, suggesting that at least part of serum Gal-3 might be produced by metastatic melanoma tissue.
  
  
  CONCLUSIONS
  Gal-3 might play a role in melanoma progression and/or inflammation, and warrants further study.
authors.affiliation: Department of Dermatology, Erasme Hospital, Brussels, Belgium. vereecken.pierre@belgacom.net
authors.forename: P
authors.initials: P
authors.lastname: Vereecken
authors.forename: K
authors.initials: K
authors.lastname: Zouaoui Boudjeltia
authors.forename: C
authors.initials: C
authors.lastname: Debray
authors.forename: A
authors.initials: A
authors.lastname: Awada
authors.forename: I
authors.initials: I
authors.lastname: Legssyer
authors.forename: F
authors.initials: F
authors.lastname: Sales
authors.forename: M
authors.initials: M
authors.lastname: Petein
authors.forename: M
authors.initials: M
authors.lastname: Vanhaeverbeek
authors.forename: G
authors.initials: G
authors.lastname: Ghanem
authors.forename: M
authors.initials: M
authors.lastname: Heenen
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002097:C-Reactive Protein / Q000032:analysis; D005260:Female; D037502:Galectin 3 / Q000097:blood*; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000097:blood; D008297:Male; D008545:Melanoma / Q000097:blood* / Q000556:secondary; D008875:Middle Aged; D009363:Neoplasm Proteins / Q000097:blood*; D009367:Neoplasm Staging; D012878:Skin Neoplasms / Q000097:blood* / Q000473:pathology; D018709:Statistics, Nonparametric
chemical_list: D037502:Galectin 3; D009363:Neoplasm Proteins; D002097:C-Reactive Protein; D007770:L-Lactate Dehydrogenase